Received Jun 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | M7YY5 | IM / LL |
Pt was due to receive dose #4 of DTaP series, but instead received a dose of TDaP. Provider, management and pt's mother were all informed. Per CDC guidelines, this TDaP dose DOES count for #4 in DTaP series. No adverse reactions have occurred/been reported